INDIANAPOLIS – GeniPhys, a medtech innovator specializing in next-generation regenerative collagen polymeric biomaterials, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, Collymer Self-Assembling Scaffold (SAS).
Artificial Intelligence (AI) has become a pervasive topic, with narratives frequently oscillating between its potential to enhance the quality of life and its potential to displace human labor. It is probable that
Insights shared by industry relative to healthcare and the advancement of medical technology. Christoph Lippuner is Co-Founded & CEO of Semble Christoph Lippuner co-founded Semble after witnessing the challenges of a fragmented
MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Tom Looby is CEO at Toronto-based Conavi Medical. With more than 25 years of experience, he
Introduction: A Wake-Up Call from Recent History In the world of MedTech, traditional development processes often slow down innovation. Medical device manufacturers face an environment where global disruptions—like shifting regulatory landscapes, geopolitical
The healthcare sector in the US accounts for 8.5% of greenhouse gas emissions[i], compared to the global healthcare footprint of almost 5%[ii]. The Health Sector Climate Pledge, committing to reduce greenhouse gas
In a watershed moment for the diagnostic test industry, the Food and Drug Administration (FDA) this April issued a long-anticipated rule overhauling how Laboratory Developed Tests (LDTs) are regulated. The rule aligns
Artificial intelligence (AI) has become one of the most exciting and promising technologies in health care and MedTech, thanks to its ability to shift through huge volumes of data and quickly detect
Lorem ipsum dolor sit amet, ei officiis assueverit pri, duo volumus commune molestiae ad, cum at clita latine. Tation nominavi quo id. An est possit adipiscing, error tation qualisque vel te. Stet